1. Blaydes, J. P. & Wynford-Thomas, D. (1996). Loss of responsiveness to transforming growth factor β is tightly linked to tumorigenicity in a model of thyroid tumour progression. Int J Cancer 65: 525–530.
2. Bongarzone, I., Pierotti, M. A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R., Pilotti, S., Grieco, M., Santoro, M., Fusco, A., Vecchio, G. & Della Porta, G. (1989). High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4: 1457–1462.
3. Boyer, J. C., Umar, A., Risinger, J. I., Lipford, J. R., Kane, M., Yin, S., Barrett, J. C., Kolodner, R. D. & Kunkel, T. A. (1995). Microsatellite instability, mismatch repair deficiency and genetic defects in human cancer cell lines. Cancer Res 55: 6063–6070.
4. Brattain, M. G., Markowitz, S. D. & Willson, J. K. V. (1996). The type II transforming growth factor β receptor as a tumour suppressor gene. Curr Opin Oncol 8: 49–53.
5. Civitelli, S., Taurini, G., Cetta, F., Petracci, M., Pacchiarotti, M. C. & Civitelli, B. (1996). Papillary thyroid carcinoma in 3 siblings with familial adenomatous polyposis. Int J Colorectal Dis 11: 571–574.